Driven by Innovation and Passion
We constantly seek exciting prospects for collaboration with external research institutions and stem cell donor registries. Whether it's for specific projects or long-term partnerships, we are eager to join forces. With more than two decades of experience in stem cell donor typing and a deep understanding of workflow innovation, we pride ourselves on a rich history of fruitful collaborations with partners across the globe. Our expertise and diverse portfolio make us the ideal partner for your endeavors. If you're interested in our support for your project, we invite you to explore our range of standard services.
Alternatively, feel free to contact us directly, and let's discuss your ideas. Together, we can make a difference.
Genomic Research and Life-Saving Donor Matching
DKMS Life Science Lab is one of the most innovative laboratories in genomic research and donor matching worldwide. Having more than 25 years of experience in the field of HLA typing, we invite you to join us in a collaborative partnership that will meet your scientific needs and make a difference in patients’ lives.
What sets us apart is our commitment to providing high-quality results at minimal cost, thanks to highly automated lab processes and diverse workflow options.
The advantages of working with us
Cooperation with us will bring you numerous advantages. We will prepare a personalized offer that aligns precisely with your requirements regardless of the number of samples you want to be typed. Our dedicated team will work closely with you to ensure every aspect of your project is addressed effectively and efficiently.
What testifies to our reputation are numerous established strong collaborations with prestigious institutions, including registries such as Matchis or Gift of Life, renowned scientific and research centers such as Universitätsklinikum Carl Gustav Carus Dresden, and esteemed pharmaceutical companies.
Here is the list of papers using our typing to develop scientific research.
Recent Papers & Publications
- Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia, Heidenreich, F; Falk, B; Baldauf, H; Massalski, C; Schäfer, G; Rücker-Braun, E; Altmann, H; Sauter, J; Solloch, U V; Lange, V; Stölzel, F; Röllig, C; Middeke, J M; von Bonin, M; Thiede, C; Schäfer-Eckart, K; Müller-Tidow, C; Krause, S W; Kraus, S; Kaufmann, M; Hänel, M; Serve, H; Neubauer, A; Bornhäuser, M; Schmidt, A H; Schetelig, J; et al., Blood Advances, 2023
- Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61, Schetelig, J; Baldauf, H; Wendler, S; Heidenreich, F; Real, R; Kolditz, M; Rosner, A; Dalpke, A; de With, K; Lange, V; Markert, J; Barth, R; Bunzel, C; Endert, D; Hofmann, J A; Sauter, J; Bernas, S N; Schmidt, A H; Deutsches Ärzteblatt Int, 2021
- CCR5Δ32 mutations do not determine COVID-19 disease course, Bernas, S N; Baldauf, H; Wendler, S; Heidenreich, F; Lange, V; Hofmann, J A; Sauter, J; Schmidt, A H; Schetelig J; International Journal of Infectious Diseases, 2021
- DR2S: an integrated algorithm providing reference-grade haplotype sequences from heterozygous samples, Klasberg, S; Schmidt, A H; Lange, V; Schöfl G; BMC Bioinformatics, 2021
- High-throughput Interpretation of Killer-cell Immunoglobulin-like Receptor Short-read Sequencing Data with PING, Marin, W M; Dandekar, R; Augusto, D G; Yusufali, T; Heyn, B; Hofmann, J; Lange, V; Sauter, J; Norman, P J; Hollenbach J A; PLOS Computational BIology, 2021
- Should results of HLA haplotype frequency estimations be normalized?, Seitz, S; Lange, V; Norman, P J; Sauter, J; Schmidt A H; International Journal of Immunogenetic, 2021
- Estimating HLA haplotype frequencies from homozygous individuals – A Technical Report, Seitz, S; Lange, V; Norman, P J; Sauter, J; Schmidt A H; International Journal of Immunogenetic, 2021
- Reanalysis of unclear CMV status results from buccal swab samples of potential stem cell donors is an efficient donor registry strategy, Bernas, S N; Behrens, G A; Baldauf, H; Baier, D M; Fischer, H; Pruschke, J; Heidenreich, F; Ruhner, K; Hofmann, J A; Markert, J; Schetelig, J; Lange, V; Schmidt, A H; Transplant Immunology, 2021
Benefit from our cutting-edge technologies
At DKMS Life Science Lab, we employ state-of-the-art technologies, utilizing the NGS Amplicon method with our in-house developed reagents for high throughput analyses. For rapid and accurate typing, we leverage NGS Shotgun or rSSO Luminex with our in-house developed or CE-IVD reagents. We accommodate various sample types, including buccal swabs, blood, or DNA, ensuring flexibility and convenience for our collaborators.
In 2017, we successfully developed a method for CMV status analysis from buccal swabs. Since then we have been excelling in the process to ensure the best quality of our analysis. This pioneering achievement showcases our commitment to pushing the boundaries of research and highlights our capability to innovate and solve complex challenges.
The quality of our work
Commitment to quality and accuracy is the foundation of our work. We hold the DIN EN ISO 15189 accreditation by DAkkS, the official accreditation from the European Federation for Immunogenetics (EFI), Good Manufacturing Practice (GMP), and the Central Bone Marrow Donor Registry Germany, demonstrating our adherence to the highest industry standards and regulations.
Let's explore the possibilities
Contact us today to start our collaboration and let your ideas become reality. Together, we will accelerate scientific breakthroughs, advance genomic research, and improve the chances of finding matches for needy patients.
Reach out to us via email at lab-services@dkms-lab.de.